Jeff Geschwind, MD – Cage Pharma Founder Jeff Geschwind, MD, founded Cage Pharma, focusing on cancer metabolism drugs. His research targets glycolysis inhibition, offering new hope for aggressive tumor treatments. https://www.eurekalert.org/multimedia/645474